Your browser doesn't support javascript.
loading
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF).
Arkenau, Hendrik-Tobias; Martin-Liberal, Juan; Calvo, Emiliano; Penel, Nicolas; Krebs, Matthew G; Herbst, Roy S; Walgren, Richard A; Widau, Ryan C; Mi, Gu; Jin, Jin; Ferry, David; Chau, Ian.
Afiliação
  • Arkenau HT; Drug Development Unit, Sarah Cannon Research Institute UK, London, United Kingdom tobias.arkenau@hcahealthcare.co.uk.
  • Martin-Liberal J; Cancer Institute, University College London, London, United Kingdom.
  • Calvo E; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Penel N; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Krebs MG; Early Clinical Drug Development Program, START Madrid-HM CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
  • Herbst RS; Centre Oscar Lambret, Lille, France.
  • Walgren RA; The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.
  • Widau RC; Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut, USA.
  • Mi G; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Jin J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Ferry D; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Chau I; Eli Lilly and Company, New York, New York, USA.
Oncologist ; 23(12): 1407-e136, 2018 12.
Article em En | MEDLINE | ID: mdl-29853658
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article